At ASH 2025, Fulcrum presented promising data on a sickle cell pill and Incyte is pioneering a new way to treat myelofibrosis ...

Incyte's data bolster efforts to develop a new type of drug for myelofibrosis, and suggest it may be a replacement for Jakafi ...

A higher dose of the experimental pill for sickle cell disease showed more promise, Fulcrum said at the American Society of ...

Gilead and Arcellx reported promising data for their CAR-T therapy anito-cel at the annual American Society of Hematology ...

A new report looks at Chinese biotech innovation capturing the attention of pharmaceutical executives and investors worldwide ...